Press Releases
See the latest from ProtoKinetix
Review our press releases for information about our current research, recent findings and key milestones. If you want to follow along our journey of cell survival, subscribe to our newsletter so you never miss an update.

Mar 09, 2017
St. Marys, West Virginia ProtoKinetix, Incorporated (OTC: PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) today announced the start of a Phase 1 first-in-human clinical trial of AAGP® PKX-001 treated islet cells […]

Feb 07, 2017
St. Marys, West Virginia ProtoKinetix, Incorporated (OTC: PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) updates its stockholders on the testing of neuronal retinal cells in living tissue at the University of […]

Jan 24, 2017
St. Marys, West Virginia ProtoKinetix, Incorporated (PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) today announced that the Governors of the University of Alberta have received a “No Objection Letter” from Health […]

Jan 17, 2017
St. Marys, West Virginia ST. MARYS, W. Va. — ProtoKinetix, Incorporated (OTC: PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) today announced that the Governors of the University of Alberta have submitted […]

Jul 14, 2016
Jul 14, 2016
ProtoKinetix’ 2nd Quarter Scientific Update St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB:PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) is pleased to provide the following corporate update to its stockholders:The management team has been very busy since […]

Jun 16, 2016
St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB:PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) is pleased to announce that it has raised US $166,000 with the sale of 4,150,000 shares of common […]
Request More Information
Talk to a member of the ProtoKinetix team to learn more about our research and results.

